<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01824576</url>
  </required_header>
  <id_info>
    <org_study_id>ACSI 5R44NS054372</org_study_id>
    <secondary_id>5R44NS054372</secondary_id>
    <nct_id>NCT01824576</nct_id>
  </id_info>
  <brief_title>Effect of Intrathoracic Pressure Regulation on Decreased Cerebral Perfusion</brief_title>
  <official_title>Physiological Effects of Intrathoracic Pressure Regulation in Patients With Decreased Cerebral Perfusion Due to Brain Injury or Intracranial Pathology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Advanced Circulatory Systems</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Neurological Disorders and Stroke (NINDS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Advanced Circulatory Systems</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to evaluate the physiological response to application of the
      Intrathoracic Pressure Regulator (ITPR) in patients with compromised cerebral circulation.
      The study will evaluate the physiological response to intrathoracic pressure regulation (IPR)
      therapy in hemodynamically stable patients with compromised cerebral circulation who are on
      ventilatory support.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Enrollment was slower than anticipated.
  </why_stopped>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">November 2016</completion_date>
  <primary_completion_date type="Actual">November 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change From Baseline in Cerebral Perfusion Pressure (CPP)</measure>
    <time_frame>During 120 minutes of device use</time_frame>
    <description>Change from average baseline CPP compared with the average CPP during use of the ITPR.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Systolic Blood Pressure (SBP)</measure>
    <time_frame>baseline to15 minutes following device use</time_frame>
    <description>Measure change in systolic blood pressure average during baseline and 15 minutes following removal of the ITPR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in PaCO2</measure>
    <time_frame>baseline and 15 minutes after device activation</time_frame>
    <description>PaCO2 will be collected during baseline and 15 minutes after device activation and change will be evaluated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Diastolic Blood Pressure (DBP)</measure>
    <time_frame>baseline to 15 minutes following device use</time_frame>
    <description>Measure change in diastolic blood pressure average during baseline and 15 minutes following removal of the ITPR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Mean Arterial Pressure (MAP)</measure>
    <time_frame>baseline to 15 minutes following device use</time_frame>
    <description>Measure change in mean arterial pressure average during baseline and 15 minutes following removal of the ITPR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Heart Rate (HR)</measure>
    <time_frame>baseline to 15 minutes following device use</time_frame>
    <description>Measure change in heart rate average during baseline and 15 minutes following removal of the ITPR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Pulse Pressure (PP)</measure>
    <time_frame>baseline to 15 minutes following device use</time_frame>
    <description>Measure change in pulse pressure average during baseline and 15 minutes following removal of the ITPR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in End-tidal Carbon Dioxide (EtCO2)</measure>
    <time_frame>baseline to 15 minutes following device use</time_frame>
    <description>Measure change in EtCO2 average during baseline and 15 minutes following removal of the ITPR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Oxygen Saturation (SpO2)</measure>
    <time_frame>basseline to 15 minutes following device use</time_frame>
    <description>Measure change in SpO2 average during baseline and 15 minutes following removal of the ITPR</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">9</enrollment>
  <condition>Head Injury</condition>
  <condition>Intracranial Pathology</condition>
  <condition>Compromised Cerebral Perfusion</condition>
  <arm_group>
    <arm_group_label>ITPR</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of the ITPR for 120 minutes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ITPR</intervention_name>
    <description>Single use noninvasive device that is connected to a vacuum source and a means to deliver a positive pressure breath. The device generates negative pressure during the expiratory phase, thus creating subatmospheric intrathoracic pressure between the periods of positive pressure ventilations.</description>
    <arm_group_label>ITPR</arm_group_label>
    <other_name>Intrathoracic Pressure Regulator</other_name>
    <other_name>CirQlator</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ≥18 years of age

          -  intubated and mechanically ventilated on a volume controlled mode

          -  head injury or other intracranial pathology and compromised cerebral perfusion

          -  arterial line in place or alternative with continuous pressure monitoring

          -  SpO2 ≥90%

          -  mean arterial pressure &gt;55

          -  admission to ICU or about to undergo neurosurgery with planned placement of an
             invasive intracranial pressure monitor

          -  inclusion presents no significant delays to planned emergent neurosurgery

          -  prior written informed consent

        Exclusion Criteria:

          -  cardiac or pulmonary injury

          -  confirmed pneumothorax or hemothorax

          -  serious neck injury resulting in neck swelling with jugular venous compression

          -  evidence of ongoing uncontrolled bleeding

          -  respiratory disease such as COPD, interstitial lung disease, or other parenchymal or
             pulmonary vascular disease

          -  marked hypertension at time of device use defined as systolic blood pressure &gt;180 mmHg

          -  congestive heart failure

          -  women with positive serum or urine pregnancy test or breast feeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Denver</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baltimore</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 29, 2013</study_first_submitted>
  <study_first_submitted_qc>April 2, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 5, 2013</study_first_posted>
  <results_first_submitted>July 6, 2017</results_first_submitted>
  <results_first_submitted_qc>August 30, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">September 27, 2017</results_first_posted>
  <last_update_submitted>August 30, 2017</last_update_submitted>
  <last_update_submitted_qc>August 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ITPR</keyword>
  <keyword>CPP</keyword>
  <keyword>TBI</keyword>
  <keyword>traumatic brain injury</keyword>
  <keyword>cerebral perfusion pressure</keyword>
  <keyword>intrathoracic pressure regulator</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Craniocerebral Trauma</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>ITPR</title>
          <description>Use of the ITPR for 120 minutes.
ITPR: Single use noninvasive device that is connected to a vacuum source and a means to deliver a positive pressure breath. The device generates negative pressure during the expiratory phase, thus creating subatmospheric intrathoracic pressure between the periods of positive pressure ventilations.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Device deficiency</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>ITPR</title>
          <description>Use of the ITPR for 120 minutes.
ITPR: Single use noninvasive device that is connected to a vacuum source and a means to deliver a positive pressure breath. The device generates negative pressure during the expiratory phase, thus creating subatmospheric intrathoracic pressure between the periods of positive pressure ventilations.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="7"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44.9" spread="13.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Cerebral Perfusion Pressure (CPP)</title>
        <description>Change from average baseline CPP compared with the average CPP during use of the ITPR.</description>
        <time_frame>During 120 minutes of device use</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ITPR</title>
            <description>Use of the ITPR for 120 minutes.
ITPR: Single use noninvasive device that is connected to a vacuum source and a means to deliver a positive pressure breath. The device generates negative pressure during the expiratory phase, thus creating subatmospheric intrathoracic pressure between the periods of positive pressure ventilations.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Cerebral Perfusion Pressure (CPP)</title>
          <description>Change from average baseline CPP compared with the average CPP during use of the ITPR.</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0" spread="6.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Systolic Blood Pressure (SBP)</title>
        <description>Measure change in systolic blood pressure average during baseline and 15 minutes following removal of the ITPR</description>
        <time_frame>baseline to15 minutes following device use</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ITPR</title>
            <description>Use of the ITPR for 120 minutes.
ITPR: Single use noninvasive device that is connected to a vacuum source and a means to deliver a positive pressure breath. The device generates negative pressure during the expiratory phase, thus creating subatmospheric intrathoracic pressure between the periods of positive pressure ventilations.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Systolic Blood Pressure (SBP)</title>
          <description>Measure change in systolic blood pressure average during baseline and 15 minutes following removal of the ITPR</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.4" spread="18.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in PaCO2</title>
        <description>PaCO2 will be collected during baseline and 15 minutes after device activation and change will be evaluated.</description>
        <time_frame>baseline and 15 minutes after device activation</time_frame>
        <population>PaCO2 values for comparison were not available for two subjects</population>
        <group_list>
          <group group_id="O1">
            <title>ITPR</title>
            <description>Use of the ITPR for 120 minutes.
ITPR: Single use noninvasive device that is connected to a vacuum source and a means to deliver a positive pressure breath. The device generates negative pressure during the expiratory phase, thus creating subatmospheric intrathoracic pressure between the periods of positive pressure ventilations.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in PaCO2</title>
          <description>PaCO2 will be collected during baseline and 15 minutes after device activation and change will be evaluated.</description>
          <population>PaCO2 values for comparison were not available for two subjects</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.7" spread="3.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Diastolic Blood Pressure (DBP)</title>
        <description>Measure change in diastolic blood pressure average during baseline and 15 minutes following removal of the ITPR</description>
        <time_frame>baseline to 15 minutes following device use</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ITPR</title>
            <description>Use of the ITPR for 120 minutes.
ITPR: Single use noninvasive device that is connected to a vacuum source and a means to deliver a positive pressure breath. The device generates negative pressure during the expiratory phase, thus creating subatmospheric intrathoracic pressure between the periods of positive pressure ventilations.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Diastolic Blood Pressure (DBP)</title>
          <description>Measure change in diastolic blood pressure average during baseline and 15 minutes following removal of the ITPR</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.5" spread="6.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Mean Arterial Pressure (MAP)</title>
        <description>Measure change in mean arterial pressure average during baseline and 15 minutes following removal of the ITPR</description>
        <time_frame>baseline to 15 minutes following device use</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ITPR</title>
            <description>Use of the ITPR for 120 minutes.
ITPR: Single use noninvasive device that is connected to a vacuum source and a means to deliver a positive pressure breath. The device generates negative pressure during the expiratory phase, thus creating subatmospheric intrathoracic pressure between the periods of positive pressure ventilations.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Mean Arterial Pressure (MAP)</title>
          <description>Measure change in mean arterial pressure average during baseline and 15 minutes following removal of the ITPR</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.9" spread="12.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Heart Rate (HR)</title>
        <description>Measure change in heart rate average during baseline and 15 minutes following removal of the ITPR</description>
        <time_frame>baseline to 15 minutes following device use</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ITPR</title>
            <description>Use of the ITPR for 120 minutes.
ITPR: Single use noninvasive device that is connected to a vacuum source and a means to deliver a positive pressure breath. The device generates negative pressure during the expiratory phase, thus creating subatmospheric intrathoracic pressure between the periods of positive pressure ventilations.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Heart Rate (HR)</title>
          <description>Measure change in heart rate average during baseline and 15 minutes following removal of the ITPR</description>
          <units>beats/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="6.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Pulse Pressure (PP)</title>
        <description>Measure change in pulse pressure average during baseline and 15 minutes following removal of the ITPR</description>
        <time_frame>baseline to 15 minutes following device use</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ITPR</title>
            <description>Use of the ITPR for 120 minutes.
ITPR: Single use noninvasive device that is connected to a vacuum source and a means to deliver a positive pressure breath. The device generates negative pressure during the expiratory phase, thus creating subatmospheric intrathoracic pressure between the periods of positive pressure ventilations.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Pulse Pressure (PP)</title>
          <description>Measure change in pulse pressure average during baseline and 15 minutes following removal of the ITPR</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.9" spread="14.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in End-tidal Carbon Dioxide (EtCO2)</title>
        <description>Measure change in EtCO2 average during baseline and 15 minutes following removal of the ITPR</description>
        <time_frame>baseline to 15 minutes following device use</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ITPR</title>
            <description>Use of the ITPR for 120 minutes.
ITPR: Single use noninvasive device that is connected to a vacuum source and a means to deliver a positive pressure breath. The device generates negative pressure during the expiratory phase, thus creating subatmospheric intrathoracic pressure between the periods of positive pressure ventilations.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in End-tidal Carbon Dioxide (EtCO2)</title>
          <description>Measure change in EtCO2 average during baseline and 15 minutes following removal of the ITPR</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Oxygen Saturation (SpO2)</title>
        <description>Measure change in SpO2 average during baseline and 15 minutes following removal of the ITPR</description>
        <time_frame>basseline to 15 minutes following device use</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ITPR</title>
            <description>Use of the ITPR for 120 minutes.
ITPR: Single use noninvasive device that is connected to a vacuum source and a means to deliver a positive pressure breath. The device generates negative pressure during the expiratory phase, thus creating subatmospheric intrathoracic pressure between the periods of positive pressure ventilations.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Oxygen Saturation (SpO2)</title>
          <description>Measure change in SpO2 average during baseline and 15 minutes following removal of the ITPR</description>
          <units>percentage of saturation</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.5" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>ITPR</title>
          <description>Use of the ITPR for 120 minutes.
ITPR: Single use noninvasive device that is connected to a vacuum source and a means to deliver a positive pressure breath. The device generates negative pressure during the expiratory phase, thus creating subatmospheric intrathoracic pressure between the periods of positive pressure ventilations.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Device deficiency</sub_title>
                <description>device made a strange noise when it was turned on</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Desaturation</sub_title>
                <description>Patient had SpO2 desaturation to 89% likely the result of a brief ventilator disconnect</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Increased ICP</sub_title>
                <description>subject’s ICP increased by &gt;10mmHg without a concurrent rise in CerPP at the end of the run-in period before device was placed</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Sr. Clinical Research Associate</name_or_title>
      <organization>Advanced Circulatory</organization>
      <phone>651.403.5606</phone>
      <email>nburkhart@zoll.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

